Weekly administration of bevacizumab, eribulin, and oxalilplatin in patients with platinum-resistant ovarian carcinomas: A phase II study with biomarker analysis

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 33; no. 15_suppl; p. 5603
Main Authors Ikeda, Yuji, Takano, Masashi, Kouta, Hiroko, Kudoh, Kazuya, Kita, Tsunekazu, Kikuchi, Ryoko, Miyamoto, Morikazu, Yoshikawa, Tomoyuki, Goto, Tomoko, Furuya, Kenichi, Tamada, Yutaka, Suga, Arata, Kikuchi, Yoshihiro
Format Journal Article
LanguageEnglish
Published 20.05.2015
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2015.33.15_suppl.5603